Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation
NEJM 392:2403-2412, 2473, Kharbanda,R.K.,et al, 2025
Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis
JAMA 316:592-601,587, Haussig, S.,et al, 2016
Stroke Recurrence in Children with Congenital Heart Disease
Ann Neurol 72:103-111, Rodan, L.,et al, 2012
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011
Does the Combination of Warfarin and Aspirin Have a Place in Secondary Stroke Prevention? No
Stroke 40:1944-1945,1946, Fisher,M., 2009
Does the Combination of Warfarin and Aspirin Have a Place in Secondary Stroke Prevention? Yes
Stroke 40:1942-1943,1946, Furlan,A.J., 2009
Antithrombotic Management of Patients with Prosthetic Heart Valves: Current Evidence and Future Trends
Lancet 374:565-576, Sun,J.C.J.,et al, 2009
Management of Anticoagulation Before and AFter Elective Surgery
NEJM 336:1506-1511, Kearon,C.&Hirsh,J., 1997
Newborn Screening and Presymptomatic Treatment of Metachromatic Leukodystrophy
NEJM 391:1256-1258, Laugwitz,L.,et al, 2024
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
"Im fine; Im just waiting for my disease" The New and Growing Class of Presymptomatic Patients
Neurol 77:522-523, Kwon, J.M.et al, 2011
Transoesophageal Echocardiography in Patients with Acute Stroke with Sinus Rhythm and No Cardiac Disease History
JNNP 81:412-415, Cho,H.-J., et al, 2010
Therapeutic Strategies After Examination by Transesophageal Echocardiography in 503 Patients with Ischemic Stroke
Stroke 37:859-864, Harloff,A.,et al, 2006
The Influence of Estrogen on Migraine
JAMA 295:1824-1830, Brandes,J.L., 2006
Adrenoleukodystrophy
JAMA 294:3131-3134, Moser,H.W.,et al, 2005
Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 291:2947-2958,3005, Shumaker,S.A.,et al, 2004
Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal Women
JAMA 291:2959-2968,3005, Espeland,M.A.,et al, 2004
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 289:2651-2662,2717, Shumaker,S.A.,et al, 2003
Cerebral Ischemic Events After Diagnosis of Mitral Valve Prolapse
Stroke 34:1339-1345, Avierinos,J.,et al, 2003
Resolution of Severe Paraplegia Due to Aortic Dissection After CSF Drainage
Neurol 61:142-143, Blacker,D.J., et al, 2003
Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women
JAMA 288:2123-2129,2170, Zandi,P.P.,et al, 2002
Hormone Replacement Therapy and Cognition
JAMA 285:1489-1499, LeBlanc,E.S.,et al, 2001
A Clinical Trial of Estrogen-Replacement Therapy After Ischemic Stroke
NEJM 345:1243-1249, Viscoli,C.M.,et al, 2001
Hormone Replacement Therapy and Reduced Cognitive Decline in Older Women
Neurol 57:2210-2216, Carlson,M.C.,et al, 2001
Risk Assessment and Anticoagulation for Primary Stroke Prevention in Atrial Fibrillation
Stroke 30:1218-1222, Kalra,L.,et al, 1999
Cognitive Function in Nondemented Older Women who Took Estrogen after Menopause
Neurol 50:368-373, Jacobs,D.M.,et al, 1998
Estrogen Therapy in Postmenopausal Women, Effects on Cognitive Function and Dementia
JAMA 279:688-695, Yaffe,K.,et al, 1998
Transesoph Echocardiogr Correl of Thromboembolism in High-Risk Pts with Nonvalv Atrial Fib
Ann Int Med 128:639-647, 6851998., Chan,K.L.,et al, 1998
Estrogen-replacement Therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging
Neurol 50:996-1002, Baldereschi,M.,et al, 1998
Postmenopausal Estrogen Use and Parkinson's Disease with and without Dementia
Neurol 50:1141-1143, Marder,K.,et al, 1998
A Prospective Study of Estrogen Replacement Therapy and the Risk of Developing Alzheimer's Disease
Neurol 48:1517-1521, Kawas,C.,et al, 1997
Hormone Replacement Therapy and Risk of Non-Fatal Stroke
Lancet 350:1277-1283, Pedersen,A.T.,et al, 1997
An Update on Primary Drug Therapies for Alzheimer Disease
Arch Neurol 54:1406-1409, Knopman,D.S.&Morris,J.C., 1997
Echocardiographic Identif of Cardiovascular Sources of Emboli to Guide Clin Manag of Stroke:Cost-Effec Analysis
Ann Int Med 127:775-787, McNamara,R.L.,et al, 1997
Effect of Oestrogen During Menopause on Risk and Age at Onset of Alzheimer's Disease
Lancet 348:429-432, 4201996., Tang,M.X.,et al, 1996
Estrogen Replacement Therapy and Risk of Alzheimer Disease
Arch Int Med 156:2213-2217, Paganinni-Hill,A.&Henderson,V.W., 1996
Primary Prevention of Stroke
NEJM 333:1392-1400, Bronner,L.L.,et al, 1995
Patent Foramen Ovale and Brain Infarct:Echocardiographic Predictors, Recurrence, and Prevention
Stroke 25:782-786, Hanna,J.P.,et al, 1994
Estrogen Replace Therapy in Older Women:Comparisons Between Alzheimer's Cases & Nondemented Cntr Subjs
Arch Neurol 51:896-900, Henderson,V.W.,et al, 1994
Hormone Replacement Therapy and the Risk of Stroke, Follow-up of Population-Based Cohort in Sweden
Arch Int Med 153:1201-1209, Falkeborn,M.,et al, 1993